Effects of Ginkgo leaf tablets on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism

References

• Chung SY, Cheng FC, Lee MS, Lin JY, Lin MC, Wang MF. 2006. Ginkgo biloba leaf extract (EGb761) combined with neuroprotective agents reduces the infarct volumes of gerbil ischemic brain. Am J Chin Med. 34:803–817.
   PubMed Web of Science ®Google Scholar
• Deng Y, Mo YF, Chen XM, Zhang LZ, Liao CF, Song Y, Xu C. 2016. Effect of Ginkgo niloba extract on the pharmacokinetics and metabolism of clopidogrel in rats. Phytother Res. 30:1886–1892.
   PubMed Web of Science ®Google Scholar
• Etheridge AS, Black SR, Patel PR, So J, Mathews JM. 2007. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and Ginseng extracts and their constituents. Planta Med. 73:731–741.
   PubMed Web of Science ®Google Scholar
• Gouws C, Steyn D, Du Plessis L, Steenekamp J, Hamman JH. 2012. Combination therapy of Western drugs and herbal medicines: recent advances in understanding interactions involving metabolism and efflux. Expert Opin Drug Metab Toxicol. 8:973–984.
   PubMed Web of Science ®Google Scholar
• Guan H, Qian D, Ren H, Zhang W, Nie H, Shang E, Duan J. 2014. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats. J Ethnopharmacol. 155:758–768.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhou X, Shi H, Shi W, Ye S, Zhang H. 2017. The effect of tripterygium glucoside tablet on pharmacokinetics of losartan and its metabolite EXP3174 in rats. Biomed Chromatogr. 31:Epub
   Web of Science ®Google Scholar
• Klishadi MS, Zarei F, Hejazian SH, Moradi A, Hemati M, Safari F. 2015. Losartan protects the heart against ischemia reperfusion injury: sirtuin3 involvement. J Pharm Pharm Sci. 18:112–123.
   PubMedGoogle Scholar
• Li H, Liu L, Xie L, Gan D, Jiang X. 2016. Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharm Biol. 54:2886–2894.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang G, Wang LS, Zhang W, Tan ZR, Fan L, Chen BL, Li Q, Liu J, Tu JH, et al. 2009. Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects. Xenobiotica. 39:788–793.
   PubMed Web of Science ®Google Scholar
• Lin CC, Cheng WL, Hsu SH, Chang CM. 2003. The effects of Ginkgo biloba extracts on the memory and motor functions of rats with chronic cerebral insufficiency. Neuropsychobiology. 47:47–51.
   PubMed Web of Science ®Google Scholar
• Liu XP, Luan JJ, Goldring CE. 2009. Comparison of the antioxidant activity amongst Gingko biloba extract and its main components. Zhong Yao Cai. 32:736–740.
   PubMedGoogle Scholar
• Palle S, Neerati P. 2017. Enhancement of oral bioavailability of rivastigmine with quercetin nanoparticles by inhibiting CYP3A4 and esterases. Pharmacol Rep. 69:365–370.
   PubMed Web of Science ®Google Scholar
• Qi XY, Liang SC, Ge GB, Liu Y, Dong PP, Zhang JW, Wang AX, Hou J, Zhu LL, Yang L, et al. 2013. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol. 56:392–397.
   PubMed Web of Science ®Google Scholar
• Rao Z, Qin H, Wei Y, Zhou Y, Zhang G, Zhang F, Shao Y, Huang J, Wu X. 2014. Development of a dynamic multiple reaction monitoring method for determination of digoxin and six active components of Ginkgo biloba leaf extract in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 959:27–35.
   PubMed Web of Science ®Google Scholar
• Rincon J, Correia D, Arcaya JL, Finol E, Fernandez A, Perez M, Yaguas K, Talavera E, Chavez M, Summer R, et al. 2015. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension. Life Sci. 124:81–90.
   PubMed Web of Science ®Google Scholar
• Spanakis M, Vizirianakis IS, Batzias G, Niopas I. 2013. Pharmacokinetic interaction between losartan and Rhodiola rosea in rabbits. Pharmacology. 91:112–116.
   PubMed Web of Science ®Google Scholar
• Turkanovic J, Ward MB, Gerber JP, Milne RW. 2017. Effect of garlic, gingko, and St. John's wort extracts on the pharmacokinetics of fexofenadine: a mechanistic study. Drug Metab Dispos. 45:569–575.
   PubMed Web of Science ®Google Scholar
• Varshney E, Saha N, Tandon M, Shrivastava V, Ali S. 2013. Genotype-phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region. Eur J Drug Metab Pharmacokinet. 38:275–282.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang H, Sun S, Wang Y, Chai Y, Yuan Y. 2016. Effect of Ginkgo leaf tablets on the pharmacokinetics of amlodipine in rats. Eur J Drug Metab Pharmacokinet. 41:825–833.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang H, Wang Y, Yu X, Yuan Y. 2016. Effects of salvianolic acid B and tanshinone IIA on the pharmacokinetics of losartan in rats by regulating the activities and expression of CYP3A4 and CYP2C9. J Ethnopharmacol. 180:87–96.
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Stevens JC. 1992. The human hepatic cytochromes P450 involved in drug metabolism. Critical Rev Toxicol. 22:1–21.
   PubMed Web of Science ®Google Scholar
• Xiaoyang L, Chenming N, Chengqing L, Tao L. 2015. Drug-drug interaction prediction between ketoconazole and anti-liver cancer drug Gomisin G. Afr Health Sci. 15:590–593.
   PubMed Web of Science ®Google Scholar
• Yang SH, Cho YA, Choi JS. 2011. Effects of ticlopidine on pharmacokinetics of losartan and its main metabolite EXP-3174 in rats. Acta Pharmacol Sin. 32:967–972.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li Y, Wang J, Sun K, Tao W, Wang Z, Xiao W, Pan Y, Zhang S, Wang Y. 2017. Systematic investigation of Ginkgo biloba leaves for treating cardio-cerebrovascular diseases in an animal model. ACS Chem Biol. 12:1363–1372.
   PubMed Web of Science ®Google Scholar
• Yasar U, Babaoglu MO, Bozkurt A. 2008. Disposition of a CYP2C9 phenotyping agent, losartan, is not influenced by the common 3435C > T variation of the drug transporter gene ABCB1 (MDR1). Basic Clin Pharmacol Toxicol. 103:176–179.
   PubMed Web of Science ®Google Scholar
• Ye L, Wang T, Tang L, Liu W, Yang Z, Zhou J, Zheng Z, Cai Z, Hu M, Liu Z. 2011. Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein. J Pharm Sci. 100:5007–5017.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhang H, Ma W, Sun S, Wang B, Zhao L, Zhang G, Chai Y. 2013. Influence of compound danshen tablet on the pharmacokinetics of losartan and its metabolite EXP3174 by liquid chromatography coupled with mass spectrometry. Biomed Chromatogr. 27:1219–1224.
   PubMed Web of Science ®Google Scholar
• Zadoyan G, Rokitta D, Klement S, Dienel A, Hoerr R, Gramatte T, Fuhr U. 2012. Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. Eur J Clin Pharmacol. 68:553–560.
   PubMed Web of Science ®Google Scholar
• Zhang JW, Liu Y, Cheng J, Li W, Ma H, Liu HT, Sun J, Wang LM, He YQ, Wang Y, et al. 2007. Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci. 10:496–503.
   PubMed Web of Science ®Google Scholar